Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice. [electronic resource]
Producer: 20090227Description: 171-81 p. digitalISSN:- 1538-7836
- Animals
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antigen-Antibody Complex -- adverse effects
- Bevacizumab
- Heparin -- physiology
- Mice
- Mice, Transgenic
- Platelet Activation -- drug effects
- Receptors, IgG -- genetics
- Thrombosis -- chemically induced
- Vascular Endothelial Growth Factor A -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.